Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy.

[1]  J. M. Lipton,et al.  Cytokine Antagonists in Infectious and Inflammatory Disorders a , 1994, Annals of the New York Academy of Sciences.

[2]  J. M. Lipton,et al.  Antiinflammatory Effects of the Neuropeptide α‐MSH in Acute, Chronic, and Systemic Inflammation a , 1994 .

[3]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[4]  Alexander Rw.  Inflammation and Coronary Artery Disease , 1994 .

[5]  J. M. Lipton,et al.  The anticytokine neuropeptide alpha-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. , 1994, Neuroimmunomodulation.

[6]  J. M. Lipton,et al.  The Neuropeptide Alpha-Melanocyte-Stimulating Hormone: A Key Component Neuroimmunomodulation , 1994 .

[7]  J. M. Lipton,et al.  Central neurogenic antiinflammatory action of alpha-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. , 1994, Neuroendocrinology.

[8]  G. Fantuzzi,et al.  Cytokines in Acute Myocardial Infarction: Selective Increase in Circulating Tumor Necrosis Factor, Its Soluble Receptor, and Interleukin‐1 Receptor Antagonist , 1994, Journal of cardiovascular pharmacology.

[9]  T. Sakamoto,et al.  Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. , 1993, American heart journal.

[10]  G. Specchia,et al.  Increased Expression of Neutrophil and Monocyte Adhesion Molecules in Unstable Coronary Artery Disease , 1993, Circulation.

[11]  R. Furth,et al.  Monocyte adherence to human vascular endothelium , 1993, Behring Institute Mitteilungen.

[12]  C. Dinarello.  Modalities for reducing interleukin 1 activity in disease. , 1993, TIPS - Trends in Pharmacological Sciences.

[13]  W. Millington,et al.  Proopiomelanocortin‐Derived Peptides and mRNA Are Expressed in Rat Heart , 1993, Annals of the New York Academy of Sciences.

[14]  J. M. Lipton,et al.  α‐Melanocyte‐Stimulating Hormone Peptides in Host Responses From Basic Evidence to Human Research a , 1993 .

[15]  Y. Başaran,et al.  Serum Tumor Necrosis Factor Levels in Acute Myocardial Infarction and Unstable Angina Pectoris , 1993, Angiology.

[16]  J. M. Lipton,et al.  α-MSH peptides inhibit acute inflammation induced in mice by rIL-1β, rIL-6, rTNF-α and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8 , 1992 .

[17]  U. Ikeda,et al.  Serum interleukin 6 levels become elevated in acute myocardial infarction. , 1992, Journal of molecular and cellular cardiology.

[18]  R. Thompson,et al.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. , 1991, Immunology today.

[19]  A. A. Taylor,et al.  Inflammation in the course of early myocardial ischemia , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  C. Maury,et al.  Circulating tumour necrosis factor‐α (cachectin) in myocardial infarction , 1989 .

[21]  D. V. Van Epps,et al.  Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by alpha-melanocyte-stimulating hormone. , 1989, Journal of immunology.

[22]  E. Smith,et al.  Temporal relation between neutrophil accumulation and myocardial reperfusion injury. , 1988, The American journal of physiology.

[23]  E. Werner,et al.  Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. , 1988, Immunology today.

[24]  S. Kunkel,et al.  Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. , 1986, American heart journal.

[25]  M. Schork,et al.  Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.

[26]  R Roberts,et al.  Deleterious effects of methylprednisolone in patients with myocardial infarction. , 1976, Circulation.

[27]  A. Catania,et al.  alpha-Melanocyte stimulating hormone in the modulation of host reactions. , 1993, Endocrine reviews.

[28]  J. Harlan,et al.  The role of adhesion molecules in reperfusion injury. , 1993, Agents and actions. Supplements.

[29]  H. Piper.  Pathophysiology of Severe Ischemic Myocardial Injury , 1990, Developments in Cardiovascular Medicine.

[30]  C. Smith,et al.  The role of leukocytes in ischemic damage, reperfusion injury and repair of the myocardium , 1990 .

[31]  C. Dinarello.  Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.

[32]  S. Goldstein.  Letter: Pacing the WPW patient. , 1976, Circulation.